AAAAAA

   
Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>

Table of contents of journal: *Journal of clinical pharmacy and therapeutics

Results: 176-200/325

Authors: PIPPALLA RS RILEY DA CHINBURAPA V
Citation: Rs. Pippalla et al., INFLUENCING THE PRESCRIBING BEHAVIOR OF PHYSICIANS - A METAEVALUATION, Journal of clinical pharmacy and therapeutics, 20(4), 1995, pp. 189-198

Authors: BRITTEN N BRANT S CAIRNS A HALL WW JONES I SALISBURY C VIRJI A HERXHEIMER A
Citation: N. Britten et al., CONTINUED PRESCRIBING OF INAPPROPRIATE DRUGS IN GENERAL-PRACTICE, Journal of clinical pharmacy and therapeutics, 20(4), 1995, pp. 199-205

Authors: CANTRILL JA DEMANUELE A DORNAN TL GARCIA S
Citation: Ja. Cantrill et al., A SURVEY OF DRUG-TREATMENT AND OUTCOMES IN DIABETIC-PATIENTS WITH ACUTE MYOCARDIAL INFARCTS, Journal of clinical pharmacy and therapeutics, 20(4), 1995, pp. 207-213

Authors: GIDAL BE PITTERLE ME SPENCER NW MALY MM
Citation: Be. Gidal et al., RELATIONSHIP BETWEEN VALPROIC ACID DOSAGE, PLASMA-CONCENTRATION AND CLEARANCE IN ADULT MONOTHERAPY PATIENTS WITH EPILEPSY, Journal of clinical pharmacy and therapeutics, 20(4), 1995, pp. 215-219

Authors: CORBETT NE PETERSON GM
Citation: Ne. Corbett et Gm. Peterson, REVIEW OF THE INITIATION OF ANTICOAGULANT-THERAPY, Journal of clinical pharmacy and therapeutics, 20(4), 1995, pp. 221-224

Authors: STURGESS R FENTONMAY V VEITCH B
Citation: R. Sturgess et al., IS THE NUMBER OF SURGICAL DAY CASES A GOOD INDICATOR OF RISING DRUG COSTS, Journal of clinical pharmacy and therapeutics, 20(4), 1995, pp. 225-228

Authors: MATAR KM NICHOLLS PJ ALHASSAN MI TEKLE A
Citation: Km. Matar et al., RAPID MICROMETHOD FOR SIMULTANEOUS MEASUREMENT OF OXCARBAZEPINE AND ITS ACTIVE METABOLITE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of clinical pharmacy and therapeutics, 20(4), 1995, pp. 229-234

Authors: GRENBY TH
Citation: Th. Grenby, DENTAL PROPERTIES OF ANTISEPTIC THROAT LOZENGES FORMULATED WITH SUGARS OR LYCASIN, Journal of clinical pharmacy and therapeutics, 20(4), 1995, pp. 235-241

Authors: MEHTA AC HARTDAVIES S KAY EA
Citation: Ac. Mehta et al., IN-VITRO DISSOLUTION STUDIES ON NIFEDIPINE CAPSULES, Journal of clinical pharmacy and therapeutics, 20(4), 1995, pp. 243-245

Authors: JOLLEY AE HASTINGS JGM
Citation: Ae. Jolley et Jgm. Hastings, THERAPEUTIC PROGRESS .4. TREATMENT AND PROPHYLAXIS OF PNEUMOCYSTIS-CARINII INFECTION, Journal of clinical pharmacy and therapeutics, 20(3), 1995, pp. 121-130

Authors: DAHL SL
Citation: Sl. Dahl, ADVANCES AND ISSUES IN THE PHARMACOTHERAPY OF RHEUMATOID-ARTHRITIS, Journal of clinical pharmacy and therapeutics, 20(3), 1995, pp. 131-147

Authors: SEWELL GJ
Citation: Gj. Sewell, PRACTICAL GUIDES .2. HOSPITAL PHARMACY QUALITY-CONTROL SERVICES, Journal of clinical pharmacy and therapeutics, 20(3), 1995, pp. 149-157

Authors: ALMESHAL MA RAMADAN MA LOTFI KM SHIBL AM
Citation: Ma. Almeshal et al., DETERMINATION OF MEROPENEM IN PLASMA BY HIGHPERFORMANCE LIQUID-CHROMATOGRAPHY AND A MICROBIOLOGICAL METHOD, Journal of clinical pharmacy and therapeutics, 20(3), 1995, pp. 159-163

Authors: RICHARDS C MILLARJONES L ALFAHAM M
Citation: C. Richards et al., ASSESSMENT OF IN-LINE FILTERS TO PROLONG THE LIFE OF INTRAVENOUS CANNULAE IN CYSTIC-FIBROSIS PATIENTS, Journal of clinical pharmacy and therapeutics, 20(3), 1995, pp. 165-166

Authors: FU KK KAI EFY LEUNG CK
Citation: Kk. Fu et al., CISPLATIN NEUROPATHY - A PROSPECTIVE CLINICAL AND ELECTROPHYSIOLOGICAL STUDY IN CHINESE PATIENTS WITH OVARIAN-CARCINOMA, Journal of clinical pharmacy and therapeutics, 20(3), 1995, pp. 167-172

Authors: TORUN M AKGUL S SARGIN H
Citation: M. Torun et al., SERUM VITAMIN-E LEVEL IN PATIENTS WITH BREAST-CANCER, Journal of clinical pharmacy and therapeutics, 20(3), 1995, pp. 173-178

Authors: FREITAG D BEBEE R SUNDERLAND B
Citation: D. Freitag et al., DIGOXIN-QUINIDINE AND DIGOXIN-AMIODARONE INTERACTIONS - FREQUENCY OF OCCURRENCE AND MONITORING IN AUSTRALIAN REPATRIATION HOSPITALS, Journal of clinical pharmacy and therapeutics, 20(3), 1995, pp. 179-183

Authors: PO ALW PEGG J BRIDGES S
Citation: Alw. Po et al., THE PLACEBO-RESPONSE - FRIEND OR FOE, Journal of clinical pharmacy and therapeutics, 20(2), 1995, pp. 47-48

Authors: KILWEIN JH
Citation: Jh. Kilwein, MEDICINE AS AN AGENCY OF SOCIAL-CONTROL .4., Journal of clinical pharmacy and therapeutics, 20(2), 1995, pp. 49-53

Authors: MILLER RS PETERSON GM MCLEAN S WESTHEAD TT GILLIES P
Citation: Rs. Miller et al., MONITORING PLASMA-LEVELS OF FLUPHENAZINE DURING CHRONIC THERAPY WITH FLUPHENAZINE DECANOATE, Journal of clinical pharmacy and therapeutics, 20(2), 1995, pp. 55-62

Authors: DOREVITCH A MERETYK I UMANSKY Y GALILIWEISSTUB E
Citation: A. Dorevitch et al., ANTIPSYCHOTIC-DRUGS AND TARDIVE-DYSKINESIA - PRELIMINARY-RESULTS IN AN ADOLESCENT PSYCHIATRIC-WARD, Journal of clinical pharmacy and therapeutics, 20(2), 1995, pp. 63-65

Authors: PAPP CM NAHATA MC
Citation: Cm. Papp et Mc. Nahata, PROSPECTIVE EVALUATION OF 10 METHODS FOR ESTIMATING CREATININE CLEARANCE IN CHILDREN WITH VARYING DEGREES OF RENAL DYSFUNCTION, Journal of clinical pharmacy and therapeutics, 20(2), 1995, pp. 67-73

Authors: MARTIBONMATI L RONCHERAOMS CL ESPINOS MA JORDAN Y LUCAS A
Citation: L. Martibonmati et al., ASSESSING THE EFFECTIVENESS OF X-RAY CONTRAST-MEDIA FOR ABDOMINAL COMPUTED TOMOGRAPHIC EXAMINATIONS - COMPARISON OF 4 LOW-OSMOLALITY AGENTS, Journal of clinical pharmacy and therapeutics, 20(2), 1995, pp. 75-81

Authors: DODSON DJ HOOTON TM BUCHWALD D
Citation: Dj. Dodson et al., PREVALENCE OF HYPERCHOLESTEROLEMIA AND CORONARY HEART-DISEASE RISK-FACTORS AMONG SOUTHEAST-ASIAN REFUGEES IN A PRIMARY-CARE CLINIC, Journal of clinical pharmacy and therapeutics, 20(2), 1995, pp. 83-89

Authors: KRSKA J MACLEOD TNN
Citation: J. Krska et Tnn. Macleod, SLEEP QUALITY AND THE USE OF BENZODIAZEPINE HYPNOTICS IN GENERAL-PRACTICE, Journal of clinical pharmacy and therapeutics, 20(2), 1995, pp. 91-96
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>